Back
Eagle Pharmaceuticals Vs. Verrica Pharmaceuticals Industry Stock Comparison
Sell
14
EGRX
Eagle Pharmaceuticals
Last Price:
0.90
Seasonality Move:
-5.96%
Sell
25
VRCA
Verrica Pharmaceuticals
Last Price:
1.00
Seasonality Move:
50.34%
Sell
14
Eagle Pharmaceuticals (EGRX)
is a Sell
Is Eagle Pharmaceuticals a Buy, Sell or Hold?
- The current Eagle Pharmaceuticals [EGRX] share price is $0.65. The Score for EGRX is 14, which is 72% below its historic median score of 50, and infers higher risk than normal.
- EGRX is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
25
Verrica Pharmaceuticals (VRCA)
is a Sell
Is Verrica Pharmaceuticals a Buy, Sell or Hold?
- The current Verrica Pharmaceuticals [VRCA] share price is $0.89. The Score for VRCA is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
- VRCA is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
EGRX Stock Price Chart
What is Eagle Pharmaceuticals's stock price today?
-
The Eagle Pharmaceuticals share price today is $0.65
The current trend is relatively stagnant and EGRX is experiencing selling pressure, which indicates risk of future bearish movement.
VRCA Stock Price Chart
What is Verrica Pharmaceuticals's stock price today?
-
The Verrica Pharmaceuticals share price today is $0.89
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VRCA is experiencing slight buying pressure.
EGRX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.22 | Sell |
| Relative Strength Index (14 RSI): | 40.32 | Sell |
| Chaikin Money Flow: | -2942 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.54 - 0.84) | Sell |
| Bollinger Bands (100): | (1.36 - 5.36) | Sell |
VRCA Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.2 | Sell |
| Relative Strength Index (14 RSI): | 37.06 | Sell |
| Chaikin Money Flow: | 17022 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.86 - 1.56) | Sell |
| Bollinger Bands (100): | (0.77 - 5.89) | Sell |
EGRX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.76 | Sell |
| 20-day SMA: | 0.68 | Sell |
| 50-day SMA: | 1.74 | Sell |
| 200-day SMA: | 4.12 | Sell |
| 8-day EMA: | 0.73 | Sell |
| 20-day EMA: | 0.83 | Sell |
| 50-day EMA: | 1.63 | Sell |
| 200-day EMA: | 4.82 | Sell |
VRCA Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.89 | Buy |
| 20-day SMA: | 1.12 | Sell |
| 50-day SMA: | 1.4 | Sell |
| 200-day SMA: | 5.05 | Sell |
| 8-day EMA: | 0.9 | Sell |
| 20-day EMA: | 1.06 | Sell |
| 50-day EMA: | 1.68 | Sell |
| 200-day EMA: | 4.04 | Sell |
Eagle Pharmaceuticals Earnings Growth & EGRX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.94 per share, and a decrease next year of $0.00 per share.
Verrica Pharmaceuticals Earnings Growth & VRCA Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.25 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.03 per share, and an increase next year of $0.82 per share.
Eagle Pharmaceuticals Technical Analysis
| Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 07 | 08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Verrica Pharmaceuticals Technical Analysis
| Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 07 | 08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||